Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

18 Apr 2014

Abstract excerpt

Because the outcome of allogeneic hematopoietic cell transplantation (HCT) is predominantly influenced by disease type and status, it is essential to be able to stratify patients undergoing HCT by disease risk. The Disease Risk Index (DRI) was developed for this purpose. In this study, we analyzed 13,131 patients reported to the Center for International Blood and Marrow Transplant Research who underwent HCT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24744269
DOI: 10.1182/blood-2014-01-552984

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPMID 24744269Read ↗

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantationSemantic proximity Read ↗

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisSemantic proximity Read ↗

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantationSemantic proximity Read ↗

Allogeneic stem cell transplantation for myelofibrosis in the modern era: single- center outcomes with DIPSS risk stratificationSemantic proximity Read ↗

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostSemantic proximity Read ↗

Comorbidities and Hematopoietic Cell Transplantation OutcomesSemantic proximity Read ↗

Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiencesSemantic proximity Read ↗

An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalSemantic proximity Read ↗

Survival Prediction in Allogeneic Haematopoietic Stem Cell Transplant Recipients Using Pre‐ and Post‐Transplant Factors and Computational IntelligenceSemantic proximity Read ↗

Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donorsSemantic proximity Read ↗

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.